Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells

M. Visweswaran, Frank Arfuso, Sudha Warrier, Arunasalam Dharmarajan

Research output: Contribution to journalReview articlepeer-review

65 Citations (Scopus)

Abstract

Emerging evidence in cancer metabolomics has identified reprogrammed metabolic pathways to be a major hallmark of cancer, among which deregulated lipid metabolism is a prominent field receiving increasing attention. Cancer stem cells (CSCs) comprise
Original languageEnglish
Pages (from-to)6-14
Number of pages9
JournalStem Cells
Volume38
Issue number1
DOIs
Publication statusPublished - 1 Jan 2020
Externally publishedYes

Fingerprint

Dive into the research topics of 'Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells'. Together they form a unique fingerprint.

Cite this